Woyach, J. A., Qiu, L., Grosicki, S., Wróbel, T., Capra, M., Czyz, J., Yi, S., Eom, K., Panovská, A., Jurczak, W., Laribi, K., Jacobasch, L., Baker, R., Agajanian, R., Berkovits, A., Ozcan, M., Lepretre, S., Coombs, C. C., Cramer, P., Lewis, K. L., Hill, M., Bao, K., Bian, Y., Ribeiro, S. R. D. B., Bhandari, N. R., Ruppert, A. S., Leow, C. C., Wierda, W. G. (2026). Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02477